Define bacterial chemotherapy and antibiotics. What are the characteristics of a good antibiotic?

You're on a roll — 1. Bacterial chemotherapy refers to the use of chemical agents (drugs) to treat bacterial infections. These agents are designed to selectively inhibit the growth of or kill bacteria without causing significant harm to the host's cells. 2. An antibiotic is a type of antimicrobial substance that is active against bacteria. It is a chemical compound, either naturally produced by microorganisms or synthetically derived, that can inhibit the growth of or kill other microorganisms, particularly bacteria, at low concentrations. 3. Characteristics of a good antibiotic include: • Selective Toxicity: It should harm the pathogen but not the host. • Broad or Narrow Spectrum: Effective against a wide range of pathogens (broad) or specific to minimize disruption of normal flora (narrow). • Bactericidal or Bacteriostatic: It should either kill bacteria (bactericidal) or inhibit their growth (bacteriostatic). • Low Side Effects: It should cause minimal adverse effects on the host. • Non-allergenic: It should not cause allergic reactions in the host. • Favorable Pharmacokinetics: It should reach the site of infection in effective concentrations and remain there for a sufficient duration. • No or Minimal Resistance Development: It should not easily lead to the development of drug resistance. • Chemically Stable: It should maintain its activity over time and under various conditions. 4. Different bacterial chemotherapeutic agents: a) Cell wall synthesis inhibitors: These agents target the bacterial cell wall, which is crucial for bacterial survival but absent in human cells, providing selective toxicity. They interfere with the synthesis of peptidoglycan, a key component of the bacterial cell wall. Examples: Penicillins (e.g., Amoxicillin), Cephalosporins (e.g., Ceftriaxone), Vancomycin. b) Protein synthesis inhibitors: These drugs target bacterial ribosomes (70S), which differ structurally from eukaryotic ribosomes (80S), allowing for selective toxicity. They interfere with various stages of protein synthesis. Examples: Tetracyclines (e.g., Doxycycline), Macrolides (e.g., Erythromycin), Aminoglycosides (e.g., Gentamicin), Chloramphenicol. c) Inhibitors of nucleic acid metabolism: These agents interfere with the synthesis or function of bacterial DNA or RNA, which are essential for bacterial replication and survival. Examples: Fluoroquinolones (e.g., Ciprofloxacin) inhibit bacterial DNA gyrase and topoisomerase IV. Rifamycins (e.g., Rifampin) inhibit bacterial RNA polymerase. Sulfonamides (e.g., Sulfamethoxazole) and Trimethoprim inhibit different steps in bacterial folic acid synthesis, which is vital for nucleotide production. 5. Differentiation between a superinfection and a superbug: • A superinfection is a new infection that arises during the course of treatment for a primary infection. It often occurs when broad-spectrum antibiotics disrupt the normal microbiota, allowing opportunistic pathogens (which may be resistant to the initial antibiotic) to proliferate and cause a secondary infection. • A superbug is a strain of bacteria that has developed resistance to multiple types of antibiotics, making it extremely difficult or impossible to treat with conventional drugs. These are highly resistant bacteria, such as Methicillin-resistant Staphylococcus aureus (MRSA) or Carbapenem-resistant Enterobacteriaceae (CRE). 6. a) The concept of antimicrobial resistance (AMR): Antimicrobial resistance occurs when microorganisms (such as bacteria, viruses, fungi, and parasites) evolve and develop the ability to withstand the effects of antimicrobial drugs that were previously effective against them. This means the drugs no longer kill or stop the growth of the microbes, making infections harder to treat and increasing the risk of disease spread, severe illness, and death. AMR is a natural evolutionary process accelerated by the misuse and overuse of antimicrobials in humans, animals, and agriculture. b) Different mechanisms bacteria use in antimicrobial resistance: • Enzymatic Inactivation/Degradation: Bacteria produce enzymes that chemically modify or destroy the antibiotic, rendering it inactive. For example, beta-lactamases break down beta-lactam antibiotics like penicillin. • Alteration of Target Site: Bacteria modify the cellular target that the antibiotic normally binds to, reducing the antibiotic's affinity for its target. For example, altered penicillin-binding proteins (PBPs) in MRSA reduce the effectiveness of beta-lactam antibiotics. • Efflux Pumps: Bacteria develop protein pumps that actively pump the antibiotic out of the bacterial cell before it can reach its target concentration. This mechanism is common in resistance to tetracyclines and macrolides. • Reduced Permeability/Uptake: Bacteria alter their outer membrane or cell wall structure to prevent or reduce the entry of the antibiotic into the cell. Changes in porin channels in Gram-negative bacteria can reduce the entry of certain antibiotics. • Bypass Metabolic Pathway: Bacteria develop alternative metabolic pathways to bypass the one inhibited by the antibiotic. For example, some bacteria can acquire external folic acid instead of synthesizing it, bypassing the action of sulfonamides. Got more? Send 'em!